Mk677 10mg

$65.00

🔬 Key Studies on MK‑677 (Ibutamoren)

1. Hip Fracture Recovery Phase IIb Study

Title: MK-0677 (ibutamoren mesylate) for treatment of patients recovering from hip fracture

  • A multicenter, randomized, placebo-controlled Phase IIb clinical trial investigating MK‑677 in elderly patients after hip fracture.

  • Outcomes included mobility, bone healing, and functional recovery. Reddit+15PubMed+15Reddit+15


2. Healthy Elderly Subjects – GH and IGF‑1

Title: Effects of MK‑677 on somatic growth, GH/IGF‑1 axis and body composition in elderly subjects

  • Daily 10–25 mg dosing in adults 64–81 years old showed up to 97% increase in GH and 88% in IGF‑1.

  • Increased lean body mass by approximately 3 kg with no change in fat mass. Raised insulin and prolactin levels modestly. PubMed+5PMC+5Wikipedia+5Wikipedia


3. Obese Young Males – Bone Markers

Title: Short‑term MK‑677 treatment increases markers of bone turnover in obese males

  • In healthy men with BMI > 30, 25 mg/day for 8 weeks induced significant increases in bone formation and resorption markers (e.g., osteocalcin, IGFBP‑5). PubMed+1chemdatabank.com+1


4. Alzheimer Disease Progression Study

Title: MK‑677 in mild to moderate Alzheimer’s disease: 12‑month randomized trial

  • 563 patients received 25 mg/day or placebo for a year. IGF‑1 increased significantly, but no improvement in cognitive or functional outcomes was observed. Reddit+15PubMed+15PMC+15


5. Preclinical Animal Study – Rat Model

Title: Effect of MK‑677 on somatic growth in rats

  • Animal model confirming GH secretagogue activity and studying metabolic effects and safety endpoints in lab rodents. chemdatabank.com+2PubMed+2PubMed+2

Category: